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Amoxicillin is a semi-synthetic, orally absorbed, broad-spectrum antibiotic. It is still
widely used in the standard eradication treatment of gastric and duodenal ulcers, which
are associated with Helicobacter pylori infection, combined with a second antibiotic and
an acid-suppressing agent (1, 2). H. pylori, a prevalent human-specific pathogen, is a caus-
ative agent in chronic active gastritis (3), gastric and duodenal ulcers (4) and gastric ade-
nocarcinoma (5), one of the most common forms of cancer in humans. The mechanisms
by which H. pylori may cause gastroduodenal disease and contribute to gastric carcino-
genesis are still hypothetical.
Treatment of H. pylori remains a challenging proposition. One reason for incomplete
eradication of H. pylori is probably the short residence time of the dosage form in the
stomach so that effective antimicrobial concentration cannot be achieved in the gastric
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The purpose of the present study was to design muco-
adhesive chitosan microspheres containing amoxicillin.
Chitosan microspheres with a small particle size and good
sphericity were prepared by a spray-drying method fol-
lowed by chemical treatment with a chemical crosslink-
ing agent (glutaraldehyde). Parameters affecting the cros-
slinking extent of the crosslinking time and the concen-
tration of the crosslinker agent. Crosslinked spray-dried
chitosan microspheres were analyzed for their morpho-
logical aspects, particle size, drug entrapment efficiency,
swelling percent and in vitro drug release. Batch M4 with
a drug polymer ratio of 1:2, dissolved in minimum con-
centration of acetic acid solution treated with glutralde-
hyde, was found to be optimal giving controlled drug re-
lease for 10 h. It was found that both the increase of glu-
taraldehyde concentration and crosslinking duration de-
creased the swelling capacity of chitosan microspheres.
This could be directly correlated to drug release from the
microspheres.
Keywords: amoxicillin, prolonged/sustained release, chi-
tosan, spray dried microspheres
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mucous layer or epithelial cell surfaces where H. pylori exists (6, 7). Another reason may
be the degradation of amoxicillin in gastric acid (8). A number of researchers have pre-
pared and reported new amoxicillin formulations such as float tablets, mucoadhesive
tablets, formulations with pH-sensitive excipients, and others, which are able to reside
in the gastrointestinal tract for an extended period of time for more effective H. pylori
eradication (9, 10).
Mucoadhesive microparticles made from the naturally occurring biodegradable
polymers like chitosan have attracted considerable attention for several years in sustai-
ned drug delivery. Mucoadhesive microspheres/microparticles have advantages such as
efficient absorption and enhanced bioavailability of drugs owing to a high surface-to-
-volume ratio, a much more intimate contact with the mucus layer, and specific target-
ing of drugs to the absorption site (11–14).
Four main approaches have been proposed: ionotropic gelation with an oppositely
charged ion, simple or complex coacervation, emulsification/solvent evaporation and,
more recently, spray drying (15). The investigation of chitosan microspheres formation
by the spray drying method is justified by interesting results presented in the literature.
Chitosan microspheres obtained by this method are characterized by high sphericity
and specific surface area (16), important parameters for their application in the pharma-
ceutical field (drug delivery systems).
In this work, the chemical crosslinking of glutaraldehyde with spray-dried chitosan
microspheres is investigated. The method consists of exposure of spray-dried micro-
spheres to the cross-linking agent in the liquid phase and under mild conditions. The ef-
fect of the preparation variables (crosslinker concentration and crosslinking duration) was




Amoxicillin trihydrate was received as a gift sample from DSM Anti-infective India
Limited, India. Chitosan was received as a gift sample from the Central Institute of Fish-
eries Technology, India. All the other ingredients and chemicals were of analytical grade.
All materials used conformed with compendial requirements.
Chitosan microspheres
Microspheres were prepared by a spray-drying technique. Chitosan solutions were
prepared by dissolving chitosan in deionized water containing 0.5 % V/V acetic acid and
then adding amoxicillin solution until a clear solution formed under continuous stirring
up to 2 h at 800 rpm. The resultant solution was spray dried using LU-222 ADVANCED
lab spray drier (Labultima, India) for preparing microspheres. Preliminary batches (with
drug to polymer ratio of 1:1) were prepared and evaluated for optimization of process
parameters. After optimization of the process parameters, the concentration of chitosan
(0.5, 1 and 2 %, m/m) that would affect the characteristics of spray-dried microspheres
was studied.
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Optimization of the formula was done using different ratios (1:1, 1:2, and 1:3) of the
drug to chitosan as polymer along with varying concentrations of acetic acid, ranging
from 0.5 to 1.5 % (Table I). The flow rate of drying air was maintained at the aspirator
setting which indicated the pressure of aspirator filter vessel of –40 mbar. The inlet tem-
perature was maintained at 140 °C, feed rate 6 mL min–1, outlet temperature 90 °C, and
atomization air pressure 2 ´ 105 Pa, as optimized in preliminary trials.
Crosslinking of chitosan microspheres
The microspheres thus obtained were crosslinked with glutaraldehyde to select the
solvent, duration of crosslinking (15, 30, 60, and 120 min) and amount of the agent (5, 10
and 15 mL glutaraldehyde per 100 mg chitosan). Uncrosslinked microspheres were sus-
pended under magnetic stirring (500 rpm) in 60 mL of ethanol solution containing glu-
taraldehyde (35 %) for 120 min. Crosslinked microspheres were filtered, quickly washed
with ethanol followed by acetone and then vacuum-dried for at least 24 h.
Viscosity of solution
The viscosity of chitosan solutions of different concentrations (0.5, 1 and 2 %, m/m)
was measured using a Brookfield viscometer, Model No: LVDV-2P230, USA. The spindle
used operated at a speed of 30, 100 and 10 rpm for 0.5, 1 and 2 % (m/m) solution, resp.,
so as to get maximum torque.
Drug entrapment efficiency
Efficiency of drug entrapment was calculated in terms of entrapment efficiency (EE).
It was determined by crushing 100 mg of accurately weighed microspheres in a glass
mortar and then the powdered microspheres were suspended in 10 mL of 0.1 mol L–1
HCl (pH 1.2). After 24 hours, the solution was filtered and the filtrate was analyzed for
drug content at the maximum wavelength of 228 nm using a Systronic 1700 UV spectro-
photometer (Japan). Based on the results obtained, the microspheres providing a 200-mg
dose were taken for dissolution testing.
Scanning electron microscopy (SEM)
Scanning electron photomicrographs of chitosan mucoadhesive microspheres were
taken. A small amount of microspheres was spread over a metal stub. Afterwards, the
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Table I. Formulation composition
M1 M2 M3 M4 M5 M6 M7 M8 M9
Amoxicillin:
chitosana
1:1 1:1 1:1 1:2 1:2 1:2 1:3 1:3 1:3
Acetic acid (%) 0.5 1.0 1.5 0.5 1.0 1.5 0.5 1.0 1.5
a Mass ratio.
stub containing the sample was placed in the scanning electron microscope (JSM 5610
LV SEM, JEOL, Japan) chamber. SEM was performed at the acceleration voltage of 20 kV,
chamber pressure of 80 Pa, at different magnifications.
Particle size of microspheres
The particle size of microspheres was determined by using a laser particle size ana-
lyzer from Brookhaven Instruments Corp., USA. A small amount of dry microspheres
was suspended in ethanol (10 mL). A volume of 2–3 mL of this suspension was then
placed into disposable cells and the particle size was measured with a standard 35 mW
diode laser.
Mucoadhesive property of microspheres
Mucoadhesive properties of the microspheres were evaluated by the in vitro wash-
-off test as reported by Lehr et al (11). A piece of rat stomach (2 ´ 2 cm) was tied onto a
plastic slide using thread. Microspheres were spread (~100) over the wet rinsed tissue
specimen and the prepared slide was hung onto one of the groves of a USP tablet dis-
inegrating test apparatus (17). The disintegrating test apparatus was switched on, whereby
the tissue specimen was given regular up and down movements in the beaker of the ap-
paratus, which contained distilled water. At hourly intervals up to 4 hours, the number
of microspheres still adhering onto the tissue was counted.
The study was approved by the Institutional Animal Ethics Committee of Ganpat
University, India.
Swelling
Swelling of chitosan microspheres was measured gravimetrically after swelling the
microspheres in deionized water (37 °C) at pH 6.0 and measuring the change in their
mass after swelling. A certain amount of microspheres were first weighted and then in-
troduced into the medium continuously stirred at 50 rpm and allowed to swell for 120
min. Swollen samples were removed periodically (0, 1, 5, 10, 15, 30, 60, 90 and 120 min)
and their net mass was determined by first blotting their surface with filter paper to re-
move adsorbed medium on the surface and then immediately weighing them on an elec-
tronic balance. Each swelling experiment was repeated two times and the average value
was taken as the swelling degree.
In vitro drug release
The in vitro drug release test for microspheres was carried out using a USP XXIV
(17) basket apparatus containing 900 mL of freshly prepared 0.1 mol L–1 HCl maintained
at 37 ± 0.5 °C, as the medium and rotating the basket at 100 rpm. A suitable volume of
the sample was withdrawn and filtered promptly through a membrane filter disc having
an average pore diameter not greater than 1.0 mm, rejecting the first 1 mL of the filtrate.
The absorbance of the resulting solution was then measured with a UV spectrophoto-
meter.
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RESULTS AND DISCUSSION
Chitosan microspheres
After initial optimization of various process parameters, chitosan solutions (0.5, 1
and 2 %, m/m) were spray dried and examined. It was found that solutions with chito-
san concentration higher than 1.5 % were too viscous to be broken into drops with con-
trolled morphology and size. As summarized in Table II, spray-dried drug-free chitosan
microspheres were spherical in shape, with a mean particle size ranging from 2.5 to 4.1
mm. It was clear from the study that the mean size of droplets formed by atomization
was proportional to liquid viscosity and surface tension (18) and indirectly affected the
spray-dried powder size. Fig. 1 shows the almost spherical form of microspheres, regar-
dless of the chitosan concentration in aqueous solution. The microspheres were able to
take up a good amount of water, reaching balanced swelling (about 65 and 80 % for 0.5
and 1 %, m/m, chitosan) after a 60 min incubation period.
On the basis of the preliminary studies, a number of batches (M1-M9, Table I) were
planned. As given in Table III, EE for all batches was found to be above 85 %. The best
EE (98.9 %) was obtained with batch M5. The particle size for all batches ranged from
2.19 to 4.36 mm. Batch M5 showed the highest yield of 42.3 %.
As shown in Fig. 2a, the more concentrated and more viscous chitosan solution led
to spray-dried microspheres of higher swelling capacity. Batches M1 to M3 showed
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Table II. Influence of chitosan concentration
Chitosan solution Chitosan microspheres (spray dried)
Concentration (%, m/m) Viscosity (Pa s) Particle shape Particle size (mm) Swelling (%)
0.5 0.0244 Spherical 2.5 64
1 0.1642 Spherical 4.1 80
2 18.2000 Not formed
a) b)
Fig. 1. SEM microphotographs of chitosan microspheres obtained by spray drying from aqueous so-
lutions: a) 0.5 % (m/m) chitosan; b) 1 % (m/m) chitosan (magnification 6500x).
swelling of 64, 63 and 62 %, respectively, while batches M7 to M9 showed 88, 85 and 80 %
swelling. Fig. 3a shows that at the end of 1 h mucoadhesion of the microspheres was
lowest (66 %) for batch M3 and highest (89 %) for batches M4 and M7. After 4 h, batch
M4 still showed the highest mucoadhesion (78 %).
In vitro drug release studies were carried out on batches M1 to M9. It was found
that batches M1 to M3 released 72.3, 70.2 and 68.1 % of the drug, respectively, after half
and hour while batches M4 to M6 released 43.7, 48.9 and 46.5 % of the drug, respectively.
Drug release from batches M7 to M9 (38.4, 38.4 and 40.8 %, respectively) was lower than
that from other batches after half and hour. Fig. 4a shows that most of the drug was re-
leased during the first two hours for all the batches. After 2 h, batch M9 released 78.2 %
of the drug (the least of all the batches), while batch M1 released most all of the drug
(98.7 %). It is evident that the degree of swelling affected the drug release. In order to
control the drug release a further treatment with a crosslinking agent was planned and
the batches were evaluated.
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Table III. Characteristics of uncrosslinked chitosan microspheresa
M1 M2 M3 M4 M5 M6 M7 M8 M9
EE (%) 95.0 86.9 97.2 97.6 98.9 97.4 85.6 97.1 97.4
Yield (%) 37 28 31 36 42 20 25 28 15
Particle size
(mm)
2.19 2.37 2.34 3.42 3.49 3.56 4.36 4.11 4.29
t80 (min) 33.18 34.18 35.24 64.58 49.07 61.80 67.28 68.39 122.73
Mucoadhesion
after 1 h (%)
68 66 66 89 79 75 89 86 84
Mucoadhesion
after 4 h (%)
56 51 52 78 67 64 74 68 67



































Fig. 2. Swelling of: a) uncrosslinked chitosan microspheres; b) crosslinked chitosan microspheres:
( ) M1, ( ) M2, ( ) M3, ( ) M4, ( ) M5, ( ) M6, ( ) M7, ( ) M8, ( ) M9. Mean
± SD, n = 3.
Crosslinking of chitosan microspheres
Chitosan microspheres were crosslinked with glutaraldehyde, the most commonly
used aldehyde for crosslinking proteins (19) and also chitosan (20) for controlled deli-
very. As given in Table IV, EE for all batches was above 76 %. The best drug loading was
obtained in batch M5 (91.6 %). Morphologically, all batches were spherical. The particle
size of the batches ranged from 2.09 to 4.04 mm. Batch M5 showed the highest yield of
89.4 % (calculation based on the initial amount of uncrosslinked microspheres taken).
The percent of swelling of crosslinked microspheres, as seen in Fig. 2b, showed a si-
milar trend to that for uncrosslinked microspheres. The percent of swelling for batches
M1 to M3 (47, 42 and 41 %, respectively) was almost half that of batches M7 to M9 (75,
73 and 72 %, respectively).
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Fig. 3. Mucoadhesive property of: a) uncrosslinked chitosan microspheres after ( ) 1 h, ( ) 4 h;













































Fig. 4. In vitro drug release of: a) uncrosslinked chitosan microspheres; b) crosslinked chitosan
microspheres: ( ) M1, ( ) M2, ( ) M3, ( ) M4, ( ) M5, ( ) M6, ( ) M7, ( ) M8,
( ) M9. Mean ± SD, n = 3.
Fig. 3b shows that after 1 h mucoadhesion of the microspheres was the lowest for
batch M3, (46 %) and the highest for batch M7 (77 %). Even, after 10 h, the same batch
M7 showed the highest mucoadhesion (59 %), which could be ascribed to higher concen-
tration of chitosan in this batch compared to batches M1 to M6.
In vitro drug release studies were carried out to find out the effect of crosslinking of
batches M1-M9 on drug release. Fig. 4b shows that the crosslinking process led to the
sustaining of drug release from the microspheres. It was evident that crosslinking of
batches M1 to M3 gave faster drug release compared to batches M7 to M9, which had
higher concentration of the chitosan polymer, leading to more crosslinking and thus a
more pronounced sustaining effect. The values of t80, as given in Table IV, show that re-
lease of 80 % of the drug was fast in batches M1 to M3 (3.1 to 3.5 h). The values for
batches M4 to M6 ranged from 5.1 to 5.5 h while those for batches M7 to M9 ranged
from 9.1 to 10.1 h. The aim of the study was to get 90 % of drug release after 8 h of the in
vitro drug release study (batches M4 to M6). In general, crosslinking reduced the EE, mu-
coadhesive property, and percent swelling and prolonged the in vitro drug release time.
Microspheres of batch M4 exhibited mucoadhesion of 69, 58 and 47 % after 1, 5 and
10 h, respectively, 90.2 % EE and 63 % swelling. The t80 value of 5.5 h indicated that the
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Table IV. Characteristics of crosslinked chitosan microspheresa
M1 M2 M3 M4 M5 M6 M7 M8 M9
EE (%) 87.7 79.6 89.9 90.2 91.6 90.1 76.6 78.0 81.1
Particle size
(mm)
2.09 2.15 2.21 3.08 3.32 3.39 4.04 3.69 3.46
Yield (%) 66 87 77 78 89 78 69 70 75
t80 (h) 3.07 3.38 3.45 5.52 5.10 5.49 9.06 10.05 10.08
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Fig. 5. Effect of: a) crosslinking time on water uptake of chitosan microspheres crosslinked with
glutaraldehyde: ( ) crosslinked, ( ) uncrosslinked; b) effect of crosslinker concentration on water
uptake of chitosan microspheres. Mean ± SD, n = 3.
mucoadhesive microspheres of amoxicillin could sustain drug release for more than 8 h.
This batch was further used for the optimization of crosslinking time and crosslinker
concentration.
As shown in Fig. 5a, as the crosslinking time (15, 30, 60 and 120 min time points) in-
creased, the degree of swelling decreased. The results show that a crosslinking time of 60
minutes was sufficient to get controlled drug release for 10 h. During the optimization of
crosslinker concentration (5, 10 and 15 mL glutaraldehyde per 100 mg chitosan), it was
observed (Fig. 5b) that with the increase in crosslinker concentration, the colour of mi-
crospheres darkened from pale yellow to dark yellow along with a decrease in percent
swelling of the spheres. As illustrated, for the same treatment duration (60 min), the
spray-dried chitosan microspheres showed their swelling capacity strongly reduced when
the crosslinker concentration was increased from 5 to 15 mL per 100 mg chitosan.
CONCLUSIONS
Chitosan microspheres with sustained release properties could be obtained by a
spray drying process followed by chemical treatment with glutaraldehyde. The crosslink-
ing density of the polymer network governed the swelling of the microspheres. It could
be modified over a wide range through variation of different manufacturing conditions
such as chitosan concentration in the solution used to prepare uncrosslinked chitosan
microspheres, the crosslinking treatment duration and the concentration of the crosslin-
ker reagent. A linear relationship was found between percent swelling and the in vitro
drug release of chitosan microspheres, which might represent as a useful tool to control
properties such as permeability to solutes and bioadhesiveness by suitable adjustment
of the crosslinking extent of chitosan microspheres with glutaraldehyde. Finally, the re-
sults suggest that the spray-dried microspheres prepared from 1:2 drug to chitosan ratio
dissolved in 0.5 % acetic acid and followed by a chemical treatment with glutaraldehyde
(10 mL per 100 mg chitosan for 60 min) may be a promising way to produce good spher-
ical chitosan microspheres with a small particle size for controlled amoxicillin delivery.
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S A @ E T A K
Priprava i in vitro karakterizacija mikrosfera amoksicilina dobivenih
metodom su{enja sprejom
JIGNYASHA A. RAVAL, JAYVADAN K. PATEL i MADHABHAI M. PATEL
Cilj ovog rada bio je priprava mukoadhezivnih kitozanskih mikrosfera amoksicili-
na. Mikrosfere male veli~ine ~estica i dobre sferi~nosti pripravljene su metodom su{enja
sprejom, te obradom s glutaraldehidom kao sredstvom za umre`avanje. Stupanj umre-
`avanja ovisio je o vremenu umre`avanja i koncentraciji sredstva za umre`avanje. Umre-
`enim kitozanskim mikrosferama odre|en je oblik, veli~ina ~estica, koli~ina uklopljenog
lijeka, postotak bubrenja i in vitro osloba|anje ljekovite tvari. Pripravak M4 s optimal-
nim svojstvima i kontroliranim osloba|anjem amoksicilina tijekom 10 sati pripravljen je
pomo}u smjese polimera omjera 1:2 otopljenih u razrije|enoj octenoj kiselini, te umre`e-
nih pomo}u glutraldehida. Pove}anje koncentracije glutaraldehida i trajanja umre`ava-
nja smanjuje sposobnost bubrenja kitozanskih mikrosfera, {to je u izravnoj korelaciji s
osloba|anjem lijeka iz mikro~estica.
Klju~ne rije~i: amoksicilin, produljeno osloba|anje, kitozan, mikrosfere dobivene su{enjem sprejom
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